The Joint Corp (JYNT)

The Joint Corp. is a healthcare company that operates and franchises chiropractic clinics across the United States. Through its franchise model, the company supports clinic development and day-to-day operations by providing franchisees and staff with training, site selection assistance, construction and vendor coordination, and ongoing operational support. Its clinics focus on routine chiropractic adjustments delivered through a private-pay, non-insurance cash model. Founded in 2010 and based in Scottsdale, Arizona, The Joint Corp. is listed on the NASDAQ under the ticker JYNT as common stock.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-JYNT
$10.29
17.4% Upside
Fair
$10
14.2% Upside
Fair
Good
0.0%
August 6, 2026
88.1x
7.6x
2.1x
119.3 M
99.558 M
1.7%
48.3%
2.5
198.1%
Valuation • Fair Value

The Joint Corp (NASDAQ-JYNT) Fair Value by Valuation Model

Compare the primary fair value estimate for The Joint Corp (NASDAQ-JYNT) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$10.29

Estimated upside of 17.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$11.52

Discounted cash flow valuation reference.

Ben Graham Formula Value

$1.09

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$8.74

Earnings power value estimate.

Comps Fair Value

$9.31

Comparable-company valuation reference.

Analyst Price Target

$10

Analysts imply upside of 14.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for The Joint Corp (NASDAQ-JYNT) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for The Joint Corp (NASDAQ-JYNT)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

56.638 M

Current operating scale indicator.

Revenue Forecast

60.949 M

Forward revenue estimate.

EBITDA

2.349 M

Current operating profitability reference.

EBITDA Forecast

12.662 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review The Joint Corp (NASDAQ-JYNT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for The Joint Corp (NASDAQ-JYNT)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.85

No elevated caution signal from this screen.

Altman Z-Score

2.5

Intermediate risk zone.

FCF / Net Income

198.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for The Joint Corp (NASDAQ-JYNT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for The Joint Corp (NASDAQ-JYNT)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 6, 2026

Days to Earnings

16

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for The Joint Corp (NASDAQ-JYNT), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

The Joint Corp (NASDAQ-JYNT) Stock Forecast & Technical Outlook

Review The Joint Corp (NASDAQ-JYNT) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for The Joint Corp (NASDAQ-JYNT) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for The Joint Corp (NASDAQ-JYNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for The Joint Corp (NASDAQ-JYNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for The Joint Corp (NASDAQ-JYNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for The Joint Corp (NASDAQ-JYNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for The Joint Corp (NASDAQ-JYNT)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, The Joint Corp (NASDAQ-JYNT) has a Hold consensus, with 1 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 3
Sell 0
FAQ Fast Investor Answers

The Joint Corp (NASDAQ-JYNT) Stock FAQ

Quick answers about The Joint Corp (NASDAQ-JYNT) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$10.29
Estimated upside 17.4%
Valuation Rating
Undervalued
Estimated upside of 17.4%
Analyst Target
$10
Implied upside 14.2%
Financial Health
Good
Current financial-health read

The current fair value estimate for The Joint Corp (NASDAQ-JYNT) is $10.29. This implies an estimated upside of 17.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 17.4% versus the current market price.

The available analyst price target for The Joint Corp (NASDAQ-JYNT) is $10. The analyst target implies estimated upside of 14.2%.

The current financial health read for The Joint Corp (NASDAQ-JYNT) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for The Joint Corp (NASDAQ-JYNT) is August 6, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for The Joint Corp (NASDAQ-JYNT) is 88.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for The Joint Corp is 119.3 M.

The current enterprise value listed for The Joint Corp is 99.558 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for The Joint Corp is NASDAQ-JYNT, and the stock is listed on NASDAQ.

The Joint Corp (NASDAQ-JYNT) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for The Joint Corp is 1.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for The Joint Corp is 48.3%. Free float helps investors understand how much of the share base is available for public trading.